AEMDAETHLON MEDICAL INC

Nasdaq aethlonmedical.com


$ 0.50 $ -0.08 (-13.81 %)    

Friday, 28-Jun-2024 15:57:01 EDT
QQQ $ 479.98 $ -2.50 (-0.52 %)
DIA $ 391.11 $ -0.43 (-0.11 %)
SPY $ 544.70 $ -2.15 (-0.39 %)
TLT $ 91.77 $ -1.74 (-1.86 %)
GLD $ 215.03 $ 0.02 (0.01 %)
$ 0.4987
$ 0.52
$ 0.00 x 0
$ 0.00 x 0
$ 0.49 - $ 0.54
$ 0.37 - $ 5.00
1,660,003
na
6.93M
$ 1.25
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 06-27-2024 03-31-2024 10-K
2 02-14-2024 12-31-2023 10-Q
3 11-14-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 06-28-2023 03-31-2023 10-K
6 02-13-2023 12-31-2022 10-Q
7 11-14-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 06-28-2022 03-31-2022 10-K
10 02-14-2022 12-31-2021 10-Q
11 11-09-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 06-24-2021 03-31-2021 10-K
14 02-10-2021 12-31-2020 10-Q
15 10-28-2020 09-30-2020 10-Q
16 08-11-2020 06-30-2020 10-Q
17 06-25-2020 03-31-2020 10-K
18 02-10-2020 12-31-2019 10-Q
19 11-01-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 07-01-2019 03-31-2019 10-K
22 02-11-2019 12-31-2018 10-Q
23 11-06-2018 09-30-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
25 06-08-2018 03-31-2018 10-K
26 02-01-2018 12-31-2017 10-Q
27 11-02-2017 09-30-2017 10-Q
28 08-10-2017 06-30-2017 10-Q
29 06-28-2017 03-31-2017 10-K
30 02-10-2017 12-31-2016 10-Q
31 11-10-2016 09-30-2016 10-Q
32 08-11-2016 06-30-2016 10-Q
33 06-29-2016 03-31-2016 10-K
34 02-04-2016 12-31-2015 10-Q
35 11-16-2015 09-30-2015 10-Q
36 08-13-2015 06-30-2015 10-Q
37 06-26-2015 03-31-2015 10-K
38 02-10-2015 12-31-2014 10-Q
39 11-10-2014 09-30-2014 10-Q
40 08-14-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 aethlon-medical-q4-2024-gaap-eps-091-beats-125-estimate

Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(0.91) per share which beat the analyst consensus estimate of $(1.2...

 aethlon-medical-fy-2024-gaap-eps-486-beats-522-estimate

Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(4.86) per share which beat the analyst consensus estimate of $(5.2...

 hc-wainwright--co-maintains-buy-on-aethlon-medical-lowers-price-target-to-7

HC Wainwright & Co. analyst Vernon Bernardino maintains Aethlon Medical (NASDAQ:AEMD) with a Buy and lowers the price ta...

 aethlon-medical-prepares-for-phase-1-cancer-treatment-studies

Phase 1 Clinical Trials of the Hemopurifier® Designed to Include Patients With Solid Tumors Who Have Stable or Progressive Dise...